| # | Drug | Count |
|---|---|---|
| 0 | CARBIDOPA AND LEVODOPA | 947 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 347 |
| 2 | AMANTADINE | 286 |
| 3 | RIVASTIGMINE | 257 |
| 4 | PRAMIPEXOLE | 254 |
| 5 | QUETIAPINE | 248 |
| 6 | CLOZAPINE | 219 |
| 7 | RASAGILINE MESYLATE | 219 |
| 8 | ROTIGOTINE | 217 |
| 9 | LEVODOPA | 215 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SAFINAMIDE MESYLATE | 78 | 0.0563 |
| 1 | ALVIMOPAN | 2 | 0.0435 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 347 | 0.0394 |
| 3 | OPICAPONE | 96 | 0.0392 |
| 4 | ENTACAPONE | 147 | 0.0346 |
| 5 | APOMORPHINE HYDROCHLORIDE | 56 | 0.0332 |
| 6 | L DOPA | 8 | 0.0299 |
| 7 | AMANTADINE | 286 | 0.0219 |
| 8 | CARBIDOPA AND LEVODOPA | 947 | 0.0200 |
| 9 | RASAGILINE MESYLATE | 219 | 0.0194 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatic Amino Acid [EPC] | 1127 |
| 1 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 558 |
| 2 | Atypical Antipsychotic [EPC] | 420 |
| 3 | Benzodiazepine [EPC] | 385 |
| 4 | Nonergot Dopamine Agonist [EPC] | 381 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 311 |
| 6 | Influenza A M2 Protein Inhibitor [EPC] | 286 |
| 7 | Cholinesterase Inhibitor [EPC] | 257 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 248 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 156 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 248 | 0.0492 |
| 1 | Nonergot Dopamine Agonist [EPC] | 381 | 0.0244 |
| 2 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 558 | 0.0197 |
| 3 | Aromatic Amino Acid [EPC] | 1127 | 0.0187 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 286 | 0.0182 |
| 5 | Cholinesterase Inhibitor [EPC] | 257 | 0.0134 |
| 6 | Monoamine Oxidase Inhibitor [EPC] | 32 | 0.0103 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 18 | 0.0087 |
| 8 | Provitamin D2 Compound [EPC] | 156 | 0.0052 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |